GeneSys Technologies

GeneSys Biologics is a clinical-stage biopharmaceutical company headquartered in Hyderabad, India, dedicated to expanding global access to affordable insulin biosimilars. The company focuses on the end-to-end development and large-scale manufacturing of recombinant insulins, utilizing a "totality of evidence" approach to meet stringent global regulatory standards. GeneSys has gained significant industry attention through its strategic partnership with Civica Rx, a U.S.-based non-profit pharmaceutical company, to provide low-cost insulin to American patients. Its robust pipeline includes biosimilar versions of major insulin products such as Insulin Glargine, Insulin Lispro, and Insulin Aspart. With a state-of-the-art manufacturing facility in Genome Valley, GeneSys is positioned as a key player in the global biosimilars landscape, emphasizing scientific excellence and meaningful affordability.